Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Impact of systemic therapies on SARS-CoV-2 antibody seroprevalence in patients with immune-mediated diseases
Liz Romero-Bogado; Martina Steiner; Israel John Thuissard Vasallo; Cristina Andreu Vázquez; Teresa Navío; Santiago Muñoz-Fernández;
Med Clin. 2024;162:470-6
Influence of angiotensin receptor and converting enzyme blockers therapy in the respiratory outcome of COVID-19 hospitalized patients
Felipe B. Lima; Francisco Wilker Mustafa Gomes Muniz; Gdayllon C. Meneses; Karine C. Bezerra; Carolyne N. Moreira; André P. Aguiar; José Carlos R. Nascimento; Tainá Veras de S. Freitas; Pedro Felipe C. de Bruin; Eanes Delgado B. Pereira; Elizabeth de F. Daher; Reinaldo B. Oriá;
Med Clin. 2024;162:163-9
Impact of SARS-CoV-2 infection in patients with cardiac amyloidosis: Results of a multicentre registry
José M. Larrañaga-Moreira; Ana I. Rodriguez-Serrano; Fernando Domínguez; Andrea Lalario; Esther Zorio; Roberto Barriales-Villa;
Med Clin. 2023;161:476-82